Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quad-Shot Radiotherapy in Combination With Immune Checkpoint Inhibition for Advanced/Recurrent Head and Neck Cancer

NCT04454489 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT04454489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04454489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quad-Shot Radiotherapy in Combination With Immune Checkpoint Inhibition for Advanced/Recurrent Head and Neck Cancer
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 2
Overall status
Completed
Start date
February 25, 2021
Completion date
April 30, 2025
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced head and neck squamous cell carcinoma, locally advanced head and neck squamous cell carcinoma, metastatic head-and-neck squamous-cell carcinoma, recurrent head and neck squamous cell carcinoma, stage iii cutaneous squamous cell carcinoma of the head and neck, stage iv cutaneous squamous cell carcinoma of the head and neck